Skip to content
Screener
Hims & Hers Health logo

Hims & Hers Health

HIMS

Hims & Hers Health, Inc. operates a consumer-first digital health platform that provides access to personalized medical treatments and wellness products.

Market cap
$6.92B-30.5%
Revenue$2.6B+28.0%
Net income-$142.0M-173%
EPS (diluted)-$0.63-180%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 9, 2026 (In 1 week)
Revenue estimate$892.9M
EPS estimate$0.06

Financials

Q2 2026

Income statement

See full
Revenue$753.2M+38.2%
Gross profit$480.8M+15.5%
Operating income-$97.2M-464%
Net income-$86.3M-303%
EPS (diluted)-$0.37-318%

Balance sheet

See full
Cash & equivalents$609.8M-45.8%
Total debt$180.9M+142%
Total equity$324.1M-42.4%
Total assets$3.6B+93.3%

Cash flow

See full
CapEx$7.8M+32.1%

Valuation & ratios

Valuation

See full
Market cap$6.92B-30.5%
Enterprise value$6.49B-33.5%
P/S2.7×-1.8×

Profitability

See full
Gross margin68.4%-7.8pp
Operating margin-6%-12.2pp
Net margin-5.5%-15.1pp

Returns & leverage

See full
Return on equity-32%-73.9pp
Debt / equity0.6×+0.4×
Current ratio0.9×-4.0×

Segments

By segment

See full
Single Reporting Segment$753.2M—

By geography

See full
Non-US$131.4M—

Competitors

Profile

Hims & Hers Health, Inc. operates a consumer-first digital health platform that provides access to personalized medical treatments and wellness products. The company integrates a provider network, electronic medical records, and cloud-based pharmacy fulfillment to facilitate telehealth consultations and recurring delivery of prescription and non-prescription solutions. Its core value proposition centers on reducing the stigma and accessibility barriers associated with chronic conditions through a seamless, brand-driven digital experience.

Competitive position

A leading digital health platform focused on normalizing treatment for stigmatized conditions through a vertically integrated technology and pharmacy stack.

GeographiesUnited States, United Kingdom, Canada, European Union, Australia
Customer segmentsB2C, Patients
Business modelDirect-to-Consumer, Subscription, E-commerce, Marketplace
SuppliersPharmaceutical manufacturers, Raw material suppliers for compounding, Contract manufacturers, Cloud infrastructure providers
CustomersIndividual retail consumers, Subscription members, Brick-and-mortar retail partners
Listed2021
Employees1.0K
CEOAndrew Dudum
FilingsSEC EDGAR

FAQ

What is Hims & Hers Health's market cap?
Hims & Hers Health (HIMS) has a market capitalization of $6.9B and trades on NYSE.
What is Hims & Hers Health's revenue and profitability?
Hims & Hers Health generated $2.6B in trailing twelve-month revenue with a net loss of $142.0M, representing a net margin of -5.5%. Gross margin stands at 68.4%. The latest reported period is Q2 2026.
Who are Hims & Hers Health's competitors?
Hims & Hers Health's key competitors include Teladoc Health, Dermata Therapeutics, Inc. Common Stock, Veradermics, Incorporated, and others. These companies compete in similar markets and product categories.
Who does Hims & Hers Health partner with?
Hims & Hers Health's notable partners include Eucalyptus.
Where is Hims & Hers Health headquartered?
Hims & Hers Health is headquartered in United States of America and employs approximately 1,046 people. It has been publicly traded since 2021.